All Access Articles |
- Theravance Biopharma Faces Strategic Shift | 2026-03-23 | UNITED STATES
- Theravance Biopharma Achieves Record Sales and Profitability | 2026-03-19 | UNITED STATES
- Completion of Enrollment in Phase 3 Cypress Study for Ampreloxetine | 2025-08-25 | PHARMACEUTICAL
- Theravance Biopharma's 10-Q Report Highlights Strategic Collaboration with Viatris | 2025-08-14 | PHARMACEUTICAL
- Theravance Biopharma secures approval for Yupelri in China | 2025-06-26 | PHARMACEUTICAL